期刊文献+

肾功能不全患者冠心病的抗栓药物治疗 被引量:4

Antithrombotic therapy for coronary heart disease in patients with chronic renal insufficiency
原文传递
导出
摘要 慢性肾脏病常并发冠心病,需要积极治疗包括抗栓药物治疗,以减少心血管事件发生率及病死率。但是,肾功能不全患者出血风险增加,如果抗栓药物使用不当,即可诱发严重出血。文章将对肾功能不全时如何使用抗血小板药物、抗凝药物及纤溶药物作一讨论。 Coronary heart disease (CHD) is frequently complicated by chronic kidney disease. Treatment of CHD including antithrombotic therapy is often needed in this situation to reduce the morbidity and mortality of cardiovascular events. Because bleeding risks are obviously increased in patients with renal insufficiency (RI) , incorrect use of antithrombotic medicines would induce severe bleeding. In this review,it will be discussed in detailed how to use the antiplatelet, anticoagulation and fibrolysis medicines in patients with RI.
出处 《中国实用内科杂志》 CAS CSCD 北大核心 2011年第5期333-335,共3页 Chinese Journal of Practical Internal Medicine
关键词 肾功能不全 抗栓治疗 renal insufficiency antithrombotic therapy
  • 相关文献

参考文献18

  • 1谌贻璞.慢性肾脏病所致心血管疾病概述[J].中国实用内科杂志,2010,30(2):108-110. 被引量:7
  • 2Melloni C, Mahaffey KW. Management of acute coronary syndromes in patients with renal dysfunction [ J ]. Curr Opin Cardio1,2008,23 (4) :320 -326.
  • 3Manjunath G ,Tighiouart H, Ibrahim H, et al. Level of kidney func- tion as a risk factor for atherosclemtic cardiovascular outcomes in the community[ Jl. J Am Coil Cardiol,2003,41 ( 1 ) :47 -55.
  • 4Attallah N,Yassine L, Fisher K, et al. Risk of bleeding and rest- enosis among chronic kidney disease patients undergoing percuta- neous coronary intervention [ J ]. Clin Nephrol, 2005,64 ( 6 ) : 412 -418.
  • 5Washam JB, Adams GL. Risks and benefits of antiplatelet therapy in uremic patients [ J ]. Adv Chronic Kidney Dis, 2008,15 ( 4 ) : 370 - 377.
  • 6Trovati M, Cavalot F. Optimization of hypolipidemic and antiplate- let treatment in the diabetic patient with renal disease [ J]. J Am Soc Nephrol,2004,15 ( Suppl 1 ) : S12 - 20.
  • 7Suranyi M, Chow JS. Review: anticoagulation for haemodialysis [ J ]. Nephrology (Carhon) ,2010,15 (4) :386 - 392.
  • 8Aronoff GR,Bennett WM, Berns JS, et al. Drug Prescribing in re- nal Failure. Dose Guidelines for Adults [ M ]. 5th ed. Philadelphia: American College of Physicians,2007:85 - 86.
  • 9Anderson JL, Adams CD, Antman EM, et al. ACC/AHA 2007 guideline for the management of patients with unstable angina/ non-ST-elevation myocardial infarction : A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines:Developed in collaboration with the American College of Emergency Physicians, Society of Academic Emergency Medicine, Society for Cardiovascular Angiography and Interven- tions,and Society of Thoracic Surgeons [ J ]. J Am Coll Cardiol, 2007,50 (7) : e1 - e157.
  • 10McCullough PA, Sandberg KR, Borzak S, et al. Benefits of aspirin and beta-blockade after myocardial infarction in patients with chronic kidney disease[J]. Am Heart J, 2002,144 ( 2 ) : 226 - 232.

二级参考文献6

  • 1侯凡凡,马志刚,梅长林,戎殳,黄颂敏,刘先蓉,袁伟杰,郭云珊,王莉,何强,王秀玲,桑晓红,栗霄立.中国五省市自治区慢性肾脏病患者心血管疾病的患病率调查[J].中华医学杂志,2005,85(7):458-463. 被引量:183
  • 2Perazella MA, Khan S. Increased mortality in chronic kidney disease :a call to action [ J ]. Am J Med Sci, 2006,331 ( 3 ) : 150 -153.
  • 3McMahon LP, Parfrey PS. Cardiovascular aspects of chronic kidney disease. In : Brenner BM, ed. The Kid ney,Sth ed, Vol 2 [ J ]. Philadelphia: Saunders ,2007 : 1697 - 1727.
  • 4侯凡凡.慢性.肾脏病的心血管病变.见:王海燕主编.肾脏病学[M].3版.北京:人民卫生出版社,2008:1883-1896.
  • 5Aoki J, Ikari Y, Nakajima H ,et al. Clinical and pathologic characteristics of dilated cardiomyopathy in hemodialysis patients [ J ]. Kidney Int,2005,67 ( 1 ) :333 - 340.
  • 6Alpert MA, Ravenscraft MD. Pericardial involvement in end-stage renal disease [ J ]. Am J Med Sci,2003,325 (4) :228 - 36.

共引文献6

同被引文献33

引证文献4

二级引证文献89

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部